Mycoplasma Genitalium Screening Tool
Evaluate urethritis and cervicitis symptoms for specialized testing needs
Professional-grade screening tool to evaluate mycoplasma genitalium symptoms, risk factors, and exposure history. Get personalized recommendations for specialized testing and medical consultation based on current CDC guidelines.
Health Screening Questionnaire
Ready to Begin Screening
Click "Start Screening" to begin the confidential health evaluation
This screening takes approximately 4-6 minutes to complete
💡 Tip: Use number keys 1-4 to quickly select options, Ctrl+Enter to proceed
Screening Results
Complete Screening to View Results
Your personalized risk assessment and testing recommendations will appear here
When to Use Mycoplasma Genitalium Screening Tool
Persistent Urethritis Symptoms
If you experience ongoing urethral discharge, burning during urination, or persistent urethritis that hasn't responded to standard STI treatment.
Recurrent Cervicitis
For women experiencing recurring cervical inflammation, abnormal discharge, or pelvic pain that hasn't been explained by standard testing.
Failed STI Treatment
When standard chlamydia or gonorrhea treatment hasn't resolved symptoms, as mycoplasma genitalium requires specific antibiotic protocols.
Partner Diagnosis
If a current or previous sexual partner has been diagnosed with mycoplasma genitalium or has persistent urogenital symptoms.
Pelvic Inflammatory Disease
For women with PID symptoms or diagnosis, as mycoplasma genitalium is an emerging cause of upper genital tract infections.
Educational Assessment
Learn about mycoplasma genitalium symptoms, risk factors, and testing requirements while assessing your personal health status.
Frequently Asked Questions
What is the Mycoplasma Genitalium Screening Tool?
Our mycoplasma genitalium screening tool is a comprehensive questionnaire that evaluates symptoms, risk factors, and exposure history to help determine if you should seek specialized testing for this emerging STI. It provides personalized recommendations based on current CDC guidelines and medical research.
How accurate is this mycoplasma screening?
This tool is designed for educational purposes and initial risk assessment only. While based on CDC guidelines and medical research, it cannot replace professional medical diagnosis. The screening helps identify when specialized testing is recommended, but always consult a healthcare provider for definitive testing and treatment.
What symptoms does this tool check for?
The screening evaluates common mycoplasma genitalium symptoms including persistent urethritis, unusual discharge, pelvic pain, cervicitis symptoms, recurrent urinary tract symptoms, post-coital bleeding, and treatment-resistant infections. It also considers important risk factors and treatment history.
Is my information kept private?
Yes, all screening data is processed locally in your browser and is not stored, transmitted, or shared with any servers or third parties. Your privacy and confidentiality are fully protected throughout the screening process. We do not collect or store any personal health information.
Can mycoplasma genitalium be asymptomatic?
Yes, mycoplasma genitalium often causes no symptoms, especially in early stages. Many infections are asymptomatic, which is why specialized testing is important for sexually active individuals with persistent or recurrent urogenital symptoms that haven't responded to standard treatment.
What should I do if the screening suggests high risk?
If the screening indicates high risk, we strongly recommend consulting with a healthcare provider who can order specialized NAAT testing for mycoplasma genitalium. This requires specific testing as it's not included in standard STI panels and requires FDA-cleared molecular testing.
How is mycoplasma genitalium treated?
Mycoplasma genitalium requires specific antibiotic treatment, typically involving doxycycline followed by azithromycin or moxifloxacin, depending on resistance patterns. Treatment should always be guided by a healthcare provider and may require resistance testing due to increasing antibiotic resistance.
No comments yet. Be the first to share your thoughts!